Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Alan Nadin, Channa K. Hattotuwagama, Ian Churcher
Angewandte Chemie International Edition (2012) Vol. 51, Iss. 5, pp. 1114-1122
Closed Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

The medicinal chemist's toolbox for late stage functionalization of drug-like molecules
Tim Cernak, Kevin D. Dykstra, Sriram Tyagarajan, et al.
Chemical Society Reviews (2015) Vol. 45, Iss. 3, pp. 546-576
Closed Access | Times Cited: 1526
Organic synthesis provides opportunities to transform drug discovery
David C. Blakemore, Luis C. Misal Castro, Ian Churcher, et al.
Nature Chemistry (2018) Vol. 10, Iss. 4, pp. 383-394
Closed Access | Times Cited: 1248
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
A. Buitrago Santanilla, Erik L. Regalado, Tony Pereira, et al.
Science (2014) Vol. 347, Iss. 6217, pp. 49-53
Open Access | Times Cited: 591
Expanding the medicinal chemistry synthetic toolbox
Jonas Boström, Dean G. Brown, Robert J. Young, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 10, pp. 709-727
Closed Access | Times Cited: 590
A robustness screen for the rapid assessment of chemical reactions
Karl D. Collins, Frank Glorius
Nature Chemistry (2013) Vol. 5, Iss. 7, pp. 597-601
Closed Access | Times Cited: 572
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Swen Hoelder, Paul A. Clarke, Paul Workman
Molecular Oncology (2012) Vol. 6, Iss. 2, pp. 155-176
Open Access | Times Cited: 545
Finding the sweet spot: the role of nature and nurture in medicinal chemistry
Michael M. Hann, György M. Keserü
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 5, pp. 355-365
Closed Access | Times Cited: 387
Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry
James A. Bull, Rosemary A. Croft, Owen A. Davis, et al.
Chemical Reviews (2016) Vol. 116, Iss. 19, pp. 12150-12233
Open Access | Times Cited: 385
A green chemistry perspective on catalytic amide bond formation
Marco T. Sabatini, Lee T. Boulton, Helen F. Sneddon, et al.
Nature Catalysis (2019) Vol. 2, Iss. 1, pp. 10-17
Closed Access | Times Cited: 350
Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann
MedChemComm (2011) Vol. 2, Iss. 5, pp. 349-355
Closed Access | Times Cited: 339
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Bo Han, Xiang‐Hong He, Yanqing Liu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 3, pp. 1522-1586
Closed Access | Times Cited: 319
The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
Lewis D. Pennington, Demetri T. Moustakas
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 9, pp. 3552-3579
Closed Access | Times Cited: 300
The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis
Shane W. Krska, Daniel A. DiRocco, Spencer D. Dreher, et al.
Accounts of Chemical Research (2017) Vol. 50, Iss. 12, pp. 2976-2985
Closed Access | Times Cited: 295
Iron‐Catalyzed Cross‐Couplings in the Synthesis of Pharmaceuticals: In Pursuit of Sustainability
Aleksandra Piontek, Elwira Bisz, Michal Szostak
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 35, pp. 11116-11128
Closed Access | Times Cited: 249
Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods
Peter S. Kutchukian, James F. Dropinski, Kevin D. Dykstra, et al.
Chemical Science (2016) Vol. 7, Iss. 4, pp. 2604-2613
Open Access | Times Cited: 219
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
György M. Keserü, Daniel A. Erlanson, György G. Ferenczy, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8189-8206
Closed Access | Times Cited: 213
Designing novel building blocks is an overlooked strategy to improve compound quality
Frederick W. Goldberg, Jason G. Kettle, Thierry Kogej, et al.
Drug Discovery Today (2014) Vol. 20, Iss. 1, pp. 11-17
Closed Access | Times Cited: 195
The application of design of experiments (DoE) reaction optimisation and solvent selection in the development of new synthetic chemistry
Paul M. Murray, Fiona Bellany, Laure Benhamou, et al.
Organic & Biomolecular Chemistry (2015) Vol. 14, Iss. 8, pp. 2373-2384
Open Access | Times Cited: 181
Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery
M. García-Castro, Stefan Zimmermann, Muthukumar G. Sankar, et al.
Angewandte Chemie International Edition (2016) Vol. 55, Iss. 27, pp. 7586-7605
Closed Access | Times Cited: 171
Pharmaceutical diversification via palladium oxidative addition complexes
Mycah R. Uehling, Ryan P. King, Shane W. Krska, et al.
Science (2019) Vol. 363, Iss. 6425, pp. 405-408
Open Access | Times Cited: 166
Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
Oleksandr O. Grygorenko, Dmytro S. Radchenko, Igor Dziuba, et al.
iScience (2020) Vol. 23, Iss. 11, pp. 101681-101681
Open Access | Times Cited: 155
DNA-encoded chemical libraries
Alexander L. Satz, Andreas Brunschweiger, Mark E. Flanagan, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Closed Access | Times Cited: 125
Ketones as strategic building blocks for the synthesis of natural product-inspired compounds
Daniel J. Foley, Herbert Waldmann
Chemical Society Reviews (2022) Vol. 51, Iss. 10, pp. 4094-4120
Closed Access | Times Cited: 79
Herbal concoction Unveiled: A computational analysis of phytochemicals' pharmacokinetic and toxicological profiles using novel approach methodologies (NAMs)
Mansi Rai, Ajay Vikram Singh, Namuna Paudel, et al.
Current Research in Toxicology (2023) Vol. 5, pp. 100118-100118
Open Access | Times Cited: 47
Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
Chun‐wa Chung, Anthony Dean, James M. Woolven, et al.
Journal of Medicinal Chemistry (2011) Vol. 55, Iss. 2, pp. 576-586
Closed Access | Times Cited: 189
Page 1 - Next Page

Scroll to top